Assessment of the abuse potential of methamnetamine in rodents: a behavioral pharmacology study.
@article{Youn2021AssessmentOT, title={Assessment of the abuse potential of methamnetamine in rodents: a behavioral pharmacology study.}, author={Dong-Hyun Youn and Jin Mook Kim and Young-ki Hong and Seo-in Park and Jin-Moo Lee and Young-Hoon Kim and Chang Won Park and Mi Sun Kang}, journal={Psychopharmacology}, year={2021} }
RATIONALE
Methamnetamine (MNA; PAL-1046) is a new psychoactive substance that acts as a full biogenic amine transporter (BAT) substrate. BAT substrates promote neurotransmitter release from the nerve terminal and can be abused as stimulants. However, scientific information on the abuse potential of methamnetamine is lacking.
OBJECTIVE
We evaluated the abuse liability of methamnetamine.
METHODS
The effective dose range of methamnetamine was determined using a climbing behavior test. The…
References
SHOWING 1-10 OF 22 REFERENCES
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.
- BiologyDrug and alcohol dependence
- 2015
Rewarding and reinforcing effects of the NMDA receptor antagonist–benzodiazepine combination, zoletil®: Difference between acute and repeated exposure
- Biology, PsychologyBehavioural Brain Research
- 2012
Agents in Development for the Management of Cocaine Abuse
- Biology, PsychologyDrugs
- 2012
Four medications warranting phase II controlled clinical trials: cabergoline, reserpine, sertraline and tiagabine, and two dopamine receptor ligands that reduce cocaine self-administration in animals are also undergoing phase I human safety trials.
Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity.
- Biology, PsychologyEuropean journal of pharmacology
- 1976
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
- Biology, PsychologyBiological Psychiatry
- 2001
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
- Psychology, BiologyMolecular Psychiatry
- 2004
It is postulate that decreased dopamine function in addicted subjects results in decreased sensitivity to nondrug-related stimuli (including natural reinforcers) and disrupts frontal inhibition, both of which contribute to compulsive drug intake and impaired inhibitory control.
Novel psychoactive substances of interest for psychiatry
- Psychology, BiologyWorld psychiatry : official journal of the World Psychiatric Association
- 2015
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine‐like…
Drug reinforcement studied by the use of place conditioning in rat
- Biology, PsychologyBrain Research
- 1982
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine
- Biology, ChemistryPharmacology Biochemistry and Behavior
- 1991
Amphetamine induces dopamine efflux through a dopamine transporter channel.
- BiologyProceedings of the National Academy of Sciences of the United States of America
- 2005
It is reported that AMPH causes DAT-mediated DA efflux by two independent mechanisms: a slow process consistent with an exchange mechanism and a process that results in rapid (millisecond) bursts ofDA efflux through a channel-like mode of DAT.